Navigation Links
Xenon Enters Cardiovascular Disease Collaboration With Merck & Co., Inc.
Date:6/11/2009

VANCOUVER, Canada, June 11 /PRNewswire/ -- Xenon today announced a strategic alliance with Merck & Co., Inc., through an affiliate, to discover and develop novel small molecule candidates for the potential treatment of cardiovascular disease.

"We are very excited to be collaborating with Merck to define new therapeutics in the area of cardiovascular diseases," said Simon Pimstone, President and CEO of Xenon. "With this deal, Xenon is continuing its strategy of risk mitigation by select partnering, while retaining ownership of other programs."

In collaboration with Merck, Xenon will perform validation studies using its clinical genetics platform, as well as drug discovery and select preclinical development of small molecule compounds for those targets selected by a joint steering committee.

Under the terms of the agreement, Merck has the option to exclusively license targets and compounds from Xenon for development and commercialization. In return, Xenon receives research funding and is eligible for option exercise fees, research, development and regulatory milestone payments of up to US$94.5million for the first target and up to US$89.5 million for each subsequent target selected for drug discovery. In addition, Merck will pay Xenon undisclosed royalties on sales of products resulting from the collaboration. Xenon retains the right to develop and commercialize certain compounds for which Merck does not exercise its option.

Michael Hayden, CSO of Xenon added, "We recognize that Merck is a leading pharmaceutical company with significant presence in and commitment to the cardiovascular space and they are an ideal strategic partner for Xenon. This new alliance, which represents our fifth partnership with a major pharmaceutical company, once again highlights Xenon's R&D capabilities and validates our drug discovery platform."

About Xenon Pharmaceuticals Inc. (Xeno
'/>"/>

SOURCE Xenon Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
2. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
3. Atlanta Falcons Physical Therapy Centers Set to Launch This Fall
4. Navitas Opens New Cancer Rehabilitation Center in Albuquerque in Conjunction With New Mexico Cancer Centers
5. Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
6. Service-to-Sales Transformation at Contact Centers Hinges on Soft Skills
7. The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers
8. Community Health Centers Reveal Specific Ramifications of The Medicaid Citizenship and Identification Documentation Requirements
9. Commercial Insurers Reimbursement Rate to New Yorks Community Health Centers Jeopardizes Care
10. Pennsylvania Trauma Systems Foundation Accreditation Status for Trauma Centers
11. Vangent, Inc. Wins Spot on Centers for Medicare & Medicaid Services Enterprise System Development Contract
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... May 20, 2013 Idol lash has designed ... darker and fuller eyelashes in a matter of few weeks. ... online purchase with an extra pack offer to help more ... access this offer on the Idol lash official website. , ... increase the eyelash density up to 82% in just a ...
(Date:5/20/2013)... 20, 2013 The US Drug ... of a transvaginal mesh failure, we are now calling ... we have ever seen for women, and the damages ... a potentially huge number of US women. According to ... underwent procedures in which mesh was implanted vaginally to ...
(Date:5/20/2013)... Atlanta, GA (PRWEB) May 20, 2013 ... Vision Institute published a testimonial about how one of ... for a LASIK consultation after being diagnosed with giant ... a foreign object in the eye, and for one ... lenses that caused this allergy,” says the Medical Director ...
(Date:5/20/2013)... 2013 The Mesothelioma Victims Center ... Navy Veterans who are diagnosed with mesothelioma get shortchanged ... they, or their family members turned to a local ... of the most skilled, and experienced mesothelioma lawyers in ... mesothelioma in the US never even bother to explore ...
(Date:5/20/2013)... 20, 2013 Milpitas, Los Angeles, ... leader in enterprise-class information archiving, eDiscovery and migration ... 7.0, the latest release in the MessageSolution product ... the legal discovery lifecycle. MessageSolution will exhibit at ... CA. , As the first stop of the ...
Breaking Medicine News(10 mins):Health News:Idol Lash Eyelash Growth Enhancer Now Offered Extra Pack for Limited Time Only at HealthCareSupplementz.com 2Health News:US Drug Watchdog Now Urges Transvaginal Mesh Failure Victims With Erosion To Call Them For The Names And Contacts Of The Best Women Attorneys 2Health News:Atlanta LASIK Practice Publishes a Patient’s Testimonial About Allergy to Contact Lenses 2Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For The Names Of The Nation's Best Mesothelioma Lawyers-Better Compensation 2Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For The Names Of The Nation's Best Mesothelioma Lawyers-Better Compensation 3Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 2Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 3Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 4
... The advantage that children get from living in two-parent families ... fact that their parents are married. A new study ... in stable single-parent homes generally do as well as those ... problems. "Many of the studies that show an advantage ...
... , , , ... antimicrobial skin care company, announced today that an independent testing laboratory ... H1N1 flu virus. The test results show HandClens is 99.99% ... submit these results to the FDA as an addendum to its ...
... , , NEW YORK, Aug. ... according to The Conference Board Help-Wanted OnLine Data Series (HWOL)(TM) ... with many of the largest States now showing stable trends following about ... data, there are now three States (New York, Maryland and Virginia) where ...
... , , GREENWICH, Conn., Aug. 31 ... system for treatment of bowel incontinence. Secca Therapy is ... that affects tens of millions of Americans, both young and ... of the anal canal - tightening the muscles, producing better ...
... , , , ... WTW ) announced today the start of the second annual Lose ... obesity and hunger. Between August 30th and October 17th, as Weight ... to $1 million to two hunger fighting organizations - Share Our Strength ...
... Italy, August 31 Health Robotics today announced,that ... agreed to,immediately install its flagship CytoCare Robot during ... an exclusive 3-year distribution,licensing, and support contract with ... and Pinnaclemed desire to safely, accurately, and,cost-effectively automate ...
Cached Medicine News:Health News:Family stability may be more crucial than 2 parents for child success 2Health News:Family stability may be more crucial than 2 parents for child success 3Health News:Tests Confirm HandClens(R) Hand Sanitizer Kills H1N1 Flu Virus 2Health News:Tests Confirm HandClens(R) Hand Sanitizer Kills H1N1 Flu Virus 3Health News:Online Job Demand Up 169,000 in August, The Conference Board Reports 2Health News:Online Job Demand Up 169,000 in August, The Conference Board Reports 3Health News:Online Job Demand Up 169,000 in August, The Conference Board Reports 4Health News:Online Job Demand Up 169,000 in August, The Conference Board Reports 5Health News:Online Job Demand Up 169,000 in August, The Conference Board Reports 6Health News:Online Job Demand Up 169,000 in August, The Conference Board Reports 7Health News:Secca(R) Therapy - An Effective and Minimally Invasive Option for Treating Bowel Incontinence - Launched in the US 2Health News:Weight Watchers Launches Second Annual Lose For Good(TM) Campaign 2Health News:Weight Watchers Launches Second Annual Lose For Good(TM) Campaign 3Health News:Weight Watchers Launches Second Annual Lose For Good(TM) Campaign 4Health News:Weight Watchers Launches Second Annual Lose For Good(TM) Campaign 5Health News:Health Robotics Expands CytoCare(TM) Global Presence With National Taiwan University Hospital and Pinnaclemed 2Health News:Health Robotics Expands CytoCare(TM) Global Presence With National Taiwan University Hospital and Pinnaclemed 3Health News:Health Robotics Expands CytoCare(TM) Global Presence With National Taiwan University Hospital and Pinnaclemed 4
(Date:5/17/2013)... , May 17, 2013  Sony Biotechnology Inc. ("Sony") ... Spectral Analyzer (SP6800).  Sony will be exhibiting and taking ... be held at the San Diego ... , from May 20 - 22.  ... system, incorporating commercial audio-visual technologies into new and novel ...
(Date:5/17/2013)... , May 17, 2013  TechAtlas Group ... for their competitive landscape map for the Chronic ... over 90 international companies with drugs and devices ... CKD and its sequelae. (Logo:  ... , hypertension - renal denervation ...
(Date:5/17/2013)... Puerto Rico , May 17, 2013  Serving a ... Puerto Rico , Caribbean Imaging and Radiation Therapy ... its radiation therapy capabilities with the acquisition of an Elekta ... . Versa HD offers clinicians the versatility to deliver ... the body, while also enabling treatment of highly complex cancers ...
Breaking Medicine Technology:Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2Puerto Rico's Caribbean Imaging and Radiation Therapy Center Orders Elekta's New Versa HD System for Treatment of Cancer Patients 2
... Mesa Laboratories, Inc. (Nasdaq: MLAB ) today reported a ... non-GAAP(1) net income for the fiscal third quarter ended December 31, ... revenues increased 44% compared to the same period last fiscal year ... $4,006,000 Quarterly non-GAAP adjusted net income increased 19% ...
... Feb. 14, 2011 A commonly prescribed osteoporosis drug ... the rare, but serious condition, osteonecrosis of the jaw; ... published online in the Journal of Dental Research, ... Associations for Dental Research.  Although the findings are provocative, ...
Cached Medicine Technology:Mesa Labs Reports 44% Increase in Third Quarter Revenues 2Mesa Labs Reports 44% Increase in Third Quarter Revenues 3Mesa Labs Reports 44% Increase in Third Quarter Revenues 4Mesa Labs Reports 44% Increase in Third Quarter Revenues 5Commonly Prescribed Osteoporosis Drug Associated with Very Low Risk of Serious Jaw Disease 2Commonly Prescribed Osteoporosis Drug Associated with Very Low Risk of Serious Jaw Disease 3Commonly Prescribed Osteoporosis Drug Associated with Very Low Risk of Serious Jaw Disease 4
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 6.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 11.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 9.0 mm and length 8 mm....
Medicine Products: